相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The FKBP5-gene in depression and treatment response -: An association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort
Magnus Lekman et al.
BIOLOGICAL PSYCHIATRY (2008)
Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
Eric J. Peters et al.
PLOS ONE (2008)
Gene tests for psychiatric risk polarize researchers
Jennifer Couzin
SCIENCE (2008)
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders
M. Gratacos et al.
PHARMACOGENOMICS JOURNAL (2008)
Association of the COMT val158met variant with antidepressant treatment response in major depression
Bernhard T. Baune et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Pharmacogenetic studies in depression: a proposal for methodologic guidelines
A. Serretti et al.
PHARMACOGENOMICS JOURNAL (2008)
Variants in PDE11A and PDE1A are not associated with citalopram response
K. S. Teranishi et al.
MOLECULAR PSYCHIATRY (2007)
A monoamine oxidase B gene variant and short-term antidepressant treatment response
Andr Tadic et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C
Eugene Lin et al.
PHARMACOGENOMICS (2007)
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression
Gonzalo Laje et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2007)
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine
Keizo Yoshida et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Translating pharmacogenomics: Challenges on the road to the clinic
Jesse J. Swen et al.
PLOS MEDICINE (2007)
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort
Silvia Paddock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients
Shingo Naito et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression
Xian-Zhang Hu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Heat-shock protein-70 genes and response to antidepressants in major depression
Chi-Un Pae et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton et al.
NATURE (2007)
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study
Roy H. Perlis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression
Andre Tadic et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model
Kim M. Smits et al.
CLINICAL THERAPEUTICS (2007)
Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample
Jeffrey B. Kraft et al.
BIOLOGICAL PSYCHIATRY (2007)
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders
Zhongchun Liu et al.
NEUROSCIENCE LETTERS (2007)
A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression
Murray J. V. Wilkie et al.
PHARMACOGENETICS AND GENOMICS (2007)
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
J. Kirchheiner et al.
PHARMACOGENOMICS JOURNAL (2007)
Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population
Byung-Joo Ham et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors
Lisa M. Monteggia et al.
BIOLOGICAL PSYCHIATRY (2007)
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy
Chi-Un Pae et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pattern-recognition techniques with haplotype analysis in pharmacogenomics
Eugene Lin et al.
PHARMACOGENOMICS (2007)
The neuronal background K-2P channels: focus on TREK1
Eric Honore
NATURE REVIEWS NEUROSCIENCE (2007)
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder
Myoung-Jin Choi et al.
BRAIN RESEARCH (2006)
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response
Ma-Li Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
Hyeran Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders
Younger W. -Y. Yu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine
Carlos Berlanga et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
An artificial neural network approach to the drug efficacy of interferon treatments
Eugene Lin et al.
PHARMACOGENOMICS (2006)
Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain:: dissection of epigenetic and genetic factors
Julia K. Pinsonneault et al.
HUMAN MOLECULAR GENETICS (2006)
Gender differences in response to antidepressant treatment prescribed in primary care.: Does menopause make a difference?
Alejandra Pinto-Meza et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes:: evidence and lessons
N Craddock et al.
MOLECULAR PSYCHIATRY (2006)
Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension
JT Bell et al.
HUMAN MOLECULAR GENETICS (2006)
Variant BDNF (VAl66Met) impact on brain structure and function
KG Bath et al.
COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE (2006)
GRIF-1-kinesin-1 interactions: a confocal microscopy study
K Pozo et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin
B Arias et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A Swedish national twin study of lifetime major depression
KS Kendler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population
Eugene Lin et al.
MOLECULAR DIAGNOSIS & THERAPY (2006)
Sequence analysis of the serotonin transporter and associations with antidepressant response
JB Kraft et al.
BIOLOGICAL PSYCHIATRY (2005)
Association study of a Monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response
YWY Yu et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Sex differences in antidepressant response in recent antidepressant clinical trials
A Khan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
YH Jeon et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Depression, antidepressants and suicidality: a critical appraisal
J Licinio et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram
MJ Choi et al.
NEUROPSYCHOBIOLOGY (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
AJ Rush et al.
CONTROLLED CLINICAL TRIALS (2004)
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms
K Yoshida et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Investigation of serotonin-related genes in antidepressant response
EJ Peters et al.
MOLECULAR PSYCHIATRY (2004)
Antidepressants and the risk of suicidal behaviors
H Jick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
EB Binder et al.
NATURE GENETICS (2004)
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression
GM Murphy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
The pharmacogenomics of selective serotonin reuptake inhibitors
A Serretti et al.
PHARMACOGENOMICS JOURNAL (2004)
Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders
HJ Lee et al.
PHARMACOGENOMICS JOURNAL (2004)
Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response
SJ Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Pharmacogenetics of antidepressant medication intolerance
GM Murphy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Kainate receptors and synaptic transmission
JE Huettner
PROGRESS IN NEUROBIOLOGY (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
SSRIs antidepressant activity is influenced by Gβ3 variants
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes
CR Sinars et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin
L Wang et al.
BIOCHEMISTRY (2002)
Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression
P Zill et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein β3 subunit
D Rosskopf et al.
PHARMACOGENETICS (2002)
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders
YWY Yu et al.
MOLECULAR PSYCHIATRY (2002)
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression
R Zanardi et al.
BIOLOGICAL PSYCHIATRY (2001)
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
A Serretti et al.
MOLECULAR PSYCHIATRY (2001)
Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
BG Pollock et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
R Zanardi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
